Wealth Enhancement Advisory Services
VNDA icon

Wealth Enhancement Advisory Services’s Vanda Pharmaceuticals VNDA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Buy
97,400
+49,077
+102% +$321K ﹤0.01% 2639
2026
Q1 		$338K Buy
48,323
+24,910
+106% +$192K ﹤0.01% 2659
2025
Q4 		$190K Buy
23,413
+5,913
+34% +$32.5K ﹤0.01% 3289
2025
Q3 		$93K Buy
+17,500
New +$81K ﹤0.01% 3348

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Enhancement Advisory Services's VNDA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Vanda Pharmaceuticals (VNDA) stake by 102% in Q2 2026, buying an estimated $321K and bringing the position to 97,400 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #2639.

Wealth Enhancement Advisory Services first reported a position in VNDA in Q3 2025 and has held it in 4 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Wealth Enhancement Advisory Services held 97,400 shares of Vanda Pharmaceuticals worth $525K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 49,077 Vanda Pharmaceuticals shares in Q2 2026, an estimated $321K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2639 holding.
  • Wealth Enhancement Advisory Services first reported a position in Vanda Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.